 phase trial taxol intraven infus taxol uniqu mitot inhibitor phase II investig phase studi hypersensit reaction cremophor vehicl rate drug infus result time span intraven IV infus taxol hour premed diphenhydramin dexamethason cimetidin earli studi antitumor activ malign melanoma ovarian carcinoma phase trial taxol IV infus day premed purpos necess premed impact toxic pharmacokinet patient assess cours taxol patient hypersensit reaction routin measur myelosuppress dose-limit sporad fatal due nonhematolog toxic grade patient grade mucos patient grade neuropathi neuropathi consist revers pain paresthesia discontinu drug patient partial respons patient non-small-cel lung cancer patient adenocarcinoma unknown primari pharmacokinet valu consist occurr myelosuppress neurotox area concentr time curv auc taxol recommend phase II dose schedul taxol merit broad investig phase II level